PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Europe Middle East, and Africa and Asia-Pacific.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2018
- $78.6M
- Net income
- -$546.4M
- Total assets
- $784.1M
- Market cap
- $450.4M
- Gross margin
- 28.6%
- Operating margin
- -346.2%
- Net margin
- -341.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $160.0M
- Cost of revenue
- $114.2M
- Gross profit
- $45.8M
- Operating expenses
- $599.6M
- Operating income
- -$553.9M
- Income tax
- $318.0K
- Net income
- -$546.4M
- EPS (basic)
- $-1.82
- EPS (diluted)
- $-1.82
Balance sheet
- Total assets
- $784.1M
- Current assets
- $375.1M
- Total liabilities
- $778.7M
- Current liabilities
- $72.8M
- Shareholders’ equity
- $5.3M
Cash flow
- Operating cash flow
- -$111.2M
- Investing cash flow
- $115.4M
- Financing cash flow
- $3.4M
- Net cash flow
- $7.7M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $450.4M
- EPS (diluted)
- $-1.82
- Shares outstanding
- 331.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 27, 2010
Pacific Biosciences of California, Inc. (PACB) Stock Price
- Reported a net loss of $546.4M in FY2018.
- Revenue grew 23% from FY2021 to FY2025.
- Gross margin of 28.6%, net margin -341.5%.
- Trading 49% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
Peers & competitors
No reviews yet. Be the first to review PACIFIC BIOSCIENCES OF CALIFORNIA, INC..
Write a review
News about PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
News & sentiment via Polygon.io
Pacific Biosciences of California, Inc.: frequently asked questions
Is Pacific Biosciences of California, Inc. an American company?
Pacific Biosciences of California, Inc. is a US-based company headquartered in Menlo Park, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Pacific Biosciences of California, Inc. headquartered?
Pacific Biosciences of California, Inc. is headquartered in Menlo Park, California, United States.
Is Pacific Biosciences of California, Inc. publicly traded?
Yes — Pacific Biosciences of California, Inc. is a publicly traded company. Its stock trades under the ticker symbol PACB on the NASDAQ.
What does Pacific Biosciences of California, Inc. do?
Pacific Biosciences of California, Inc. is an American Medical Devices company in the Health & Beauty sector.
